Leffler Eugene Frederick 4

What Happened Eugene Leffler, Chief Financial Officer of Biofrontera Inc. (BFRI), received two restricted stock unit (RSU) awards on March 4, 2026 totaling 125,000 RSUs (62,500 + 62,500) at $0.00 per unit. On March 5, 2026 the filing also shows a conversion/settlement of 87,500 derivative units (reported as both an acquisition and a disposition of 87,500 shares at $0.00). The filing reports no cash exchange for the new RSU awards or the March 5 transactions.

Key Details

• Transactions reported: Mar 4, 2026 — grant/award of 62,500 RSUs and 62,500 RSUs (total 125,000) at $0.00; Mar 5, 2026 — conversion/exercise entries for 87,500 derivative securities (one acquisition and one disposition) at $0.00.
• Value: The grants and conversions are reported at $0.00 (awarded for no cash consideration; settlement may be in shares or cash per company policy).
• Shares owned after transaction: Not specified in the Form 4 provided.
• Notable footnotes:
  • RSUs convert one-for-one into common stock (F1).
  • New RSUs are contingent awards and were granted for no consideration (F2).
  • The new RSUs vest in two equal yearly installments beginning March 4, 2027 and, when vested, may be settled in shares, cash, or a combination within 60 days (F3).
  • The 87,500 settled on March 5, 2026 relates to the second tranche of a July 12, 2024 RSU grant that was settled on March 5, 2026 due to an administrative error (F5).
• Filing timeliness: Form 4 was filed on March 6, 2026. The filing does not indicate a late-reporting legend.

Context

• These transactions are primarily equity awards (RSUs) rather than open-market buys or sales. The March 5 entries reflect settlement/conversion of previously awarded RSUs (per footnote F5) and the filing shows equal acquisition and disposition entries at $0.00, consistent with administrative settlement/withholding mechanics rather than a market sale. Awards and RSU vesting schedules are disclosed; vested units may be settled in shares or cash at the company's discretion.